These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26196695)

  • 41. Methicillin-resistant Staphylococcus aureus nosocomial pneumonia patients treated with ceftaroline: retrospective case series of 10 patients.
    Pasquale TR; Tan MJ; Trienski TL; File TM
    J Chemother; 2015 Feb; 27(1):29-34. PubMed ID: 24621164
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methicillin-resistant
    Kiselinova M; Velghe A; Piers R; Verhasselt B; Van Den Noortgate N
    Acta Clin Belg; 2019 Dec; 74(6):456-459. PubMed ID: 30444192
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Comparison of teicoplanin and linezolid therapies in patients with methicillin-resistant Staphylococcus aureus pneumonia acquired from respiratory intensive care unit].
    Taşbakan MS; Korkmaz Ekren P; Pullukçu H; Başarık B; Susur A; Aydemir S; Başoğlu OK; Bacakoğlu F
    Mikrobiyol Bul; 2010 Jul; 44(3):357-66. PubMed ID: 21063985
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study.
    Rubinstein E; Cammarata S; Oliphant T; Wunderink R;
    Clin Infect Dis; 2001 Feb; 32(3):402-12. PubMed ID: 11170948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical predictors of methicillin-resistant Staphylococcus aureus in nosocomial and healthcare-associated pneumonia: a multicenter, matched case-control study.
    Torre-Cisneros J; Natera C; Mesa F; Trikic M; Rodríguez-Baño J
    Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):51-56. PubMed ID: 28887643
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of methicillin-resistant Staphylococcus aureus pneumonia.
    Luna CM; Boyeras Navarro ID
    Curr Opin Infect Dis; 2010 Apr; 23(2):178-84. PubMed ID: 20075728
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of vancomycin and linezolid in patients with peripheral vascular disease and/or diabetes in an observational European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.
    Eckmann C; Nathwani D; Lawson W; Corman S; Solem C; Stephens J; Macahilig C; Li J; Charbonneau C; Baillon-Plot N; Haider S
    Clin Microbiol Infect; 2015 Sep; 21 Suppl 2():S33-9. PubMed ID: 26198370
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of linezolid versus vancomycin on length of hospital stay in patients with complicated skin and soft tissue infections caused by known or suspected methicillin-resistant staphylococci: results from a randomized clinical trial.
    Li JZ; Willke RJ; Rittenhouse BE; Rybak MJ
    Surg Infect (Larchmt); 2003; 4(1):57-70. PubMed ID: 12744768
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outcomes associated with bacteremia in the setting of methicillin-resistant Staphylococcus aureus pneumonia: a retrospective cohort study.
    Shorr AF; Zilberberg MD; Micek ST; Kollef MH
    Crit Care; 2015 Sep; 19(1):312. PubMed ID: 26335247
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antimicrobial treatment of nosocomial meticillin-resistant Staphylococcus aureus (MRSA) pneumonia: current and future options.
    Welte T; Pletz MW
    Int J Antimicrob Agents; 2010 Nov; 36(5):391-400. PubMed ID: 20724119
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibiotic de-escalation in pneumonia with pharmacist education and ordering of methicillin-resistant
    Doan K; Smoke S
    Eur J Hosp Pharm; 2024 Jun; 31(4):327-331. PubMed ID: 36754620
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New therapy options for MRSA with respiratory infection/pneumonia.
    Ramirez P; Fernández-Barat L; Torres A
    Curr Opin Infect Dis; 2012 Apr; 25(2):159-65. PubMed ID: 22248980
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Risk factors of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus].
    Torre-Cisneros J; Tejero García R; Natera Kindelán C; Font Ugalde P; Franco Álvarez de Luna F; Castón Osorio JJ; Rivero Román A; Casal Román M
    Med Clin (Barc); 2012 Feb; 138(3):99-106. PubMed ID: 22032820
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
    Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
    Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk factors for methicillin-resistant Staphylococcus aureus in patients with community-onset and hospital-onset pneumonia.
    Wooten DA; Winston LG
    Respir Med; 2013 Aug; 107(8):1266-70. PubMed ID: 23756035
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Linezolid and vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia: the subtleties of subgroup analyses.
    Powers JH; Ross DB; Lin D; Soreth J
    Chest; 2004 Jul; 126(1):314-5; author reply 315-6. PubMed ID: 15249482
    [No Abstract]   [Full Text] [Related]  

  • 57. Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes.
    Rello J; Torres A; Ricart M; Valles J; Gonzalez J; Artigas A; Rodriguez-Roisin R
    Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1545-9. PubMed ID: 7952612
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan.
    Kohno S; Yamaguchi K; Aikawa N; Sumiyama Y; Odagiri S; Aoki N; Niki Y; Watanabe S; Furue M; Ito T; Croos-Dabrera R; Tack KJ
    J Antimicrob Chemother; 2007 Dec; 60(6):1361-9. PubMed ID: 17913720
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices.
    Jeffres MN; Isakow W; Doherty JA; McKinnon PS; Ritchie DJ; Micek ST; Kollef MH
    Chest; 2006 Oct; 130(4):947-55. PubMed ID: 17035423
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical outcomes of linezolid vs vancomycin in methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia: retrospective analysis.
    Chan JD; Pham TN; Wong J; Hessel M; Cuschieri J; Neff M; Dellit TH
    J Intensive Care Med; 2011; 26(6):385-91. PubMed ID: 21606058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.